Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
21.77
-0.44 (-1.98%)
Apr 1, 2025, 4:00 PM EDT - Market closed
KNSA Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Cash & Equivalents | 183.58 | 107.95 | 122.72 | 122.47 | 114.04 | Upgrade
|
| Short-Term Investments | 60.05 | 98.42 | 67.89 | 59.73 | 209.44 | Upgrade
|
| Cash & Short-Term Investments | 243.63 | 206.37 | 190.61 | 182.2 | 323.48 | Upgrade
|
| Cash Growth | 18.05% | 8.27% | 4.61% | -43.68% | 38.61% | Upgrade
|
| Receivables | 41.72 | 21.27 | 20.32 | 3.99 | - | Upgrade
|
| Inventory | 26.36 | 31.12 | 21.6 | 3.68 | - | Upgrade
|
| Prepaid Expenses | 20.08 | 17.54 | 10.54 | 6.59 | 9.56 | Upgrade
|
| Restricted Cash | - | - | - | - | 0.21 | Upgrade
|
| Total Current Assets | 331.8 | 276.3 | 243.06 | 196.45 | 333.25 | Upgrade
|
| Property, Plant & Equipment | 11.04 | 12.67 | 7.04 | 8.38 | 10.62 | Upgrade
|
| Other Intangible Assets | 16.25 | 17.25 | 18.25 | 19.25 | - | Upgrade
|
| Long-Term Deferred Tax Assets | 211.15 | 219.28 | 185.5 | - | 0.01 | Upgrade
|
| Other Long-Term Assets | 10.32 | 0.83 | 5.82 | 8.72 | 5.59 | Upgrade
|
| Total Assets | 580.55 | 526.32 | 459.67 | 232.8 | 349.46 | Upgrade
|
| Accounts Payable | 2.04 | 8.25 | 7.9 | 1.87 | 0.5 | Upgrade
|
| Accrued Expenses | 80.51 | 44.67 | 30.11 | 38.03 | 29.2 | Upgrade
|
| Current Portion of Leases | 1.99 | 2.25 | 3.3 | 3.38 | 2.11 | Upgrade
|
| Current Unearned Revenue | - | 0.31 | - | - | - | Upgrade
|
| Other Current Liabilities | 16.08 | 8.19 | 5.75 | 1.54 | 0.04 | Upgrade
|
| Total Current Liabilities | 100.62 | 63.67 | 47.07 | 44.82 | 31.85 | Upgrade
|
| Long-Term Leases | 7.86 | 10.01 | 2.62 | 2.67 | 4.88 | Upgrade
|
| Long-Term Unearned Revenue | 31.81 | 11.95 | 12 | - | - | Upgrade
|
| Other Long-Term Liabilities | 1.82 | 1.86 | 1.84 | 0.27 | 0.81 | Upgrade
|
| Total Liabilities | 142.12 | 87.48 | 63.52 | 47.76 | 37.53 | Upgrade
|
| Common Stock | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
| Additional Paid-In Capital | 959.72 | 916.76 | 888.12 | 860.48 | 829.42 | Upgrade
|
| Retained Earnings | -521.14 | -477.95 | -492.03 | -675.4 | -517.47 | Upgrade
|
| Comprehensive Income & Other | -0.16 | 0.01 | 0.04 | -0.07 | -0.03 | Upgrade
|
| Total Common Equity | 438.44 | 438.84 | 396.15 | 185.04 | 311.94 | Upgrade
|
| Shareholders' Equity | 438.44 | 438.84 | 396.15 | 185.04 | 311.94 | Upgrade
|
| Total Liabilities & Equity | 580.55 | 526.32 | 459.67 | 232.8 | 349.46 | Upgrade
|
| Total Debt | 9.86 | 12.26 | 5.92 | 6.05 | 6.99 | Upgrade
|
| Net Cash (Debt) | 233.77 | 194.11 | 184.69 | 176.15 | 316.5 | Upgrade
|
| Net Cash Growth | 20.43% | 5.10% | 4.85% | -44.34% | 37.17% | Upgrade
|
| Net Cash Per Share | 3.27 | 2.70 | 2.62 | 2.57 | 5.12 | Upgrade
|
| Filing Date Shares Outstanding | 72.64 | 70.62 | 69.75 | 69.1 | 68.23 | Upgrade
|
| Total Common Shares Outstanding | 72.52 | 70.46 | 69.7 | 69.06 | 68.22 | Upgrade
|
| Working Capital | 231.18 | 212.63 | 195.99 | 151.62 | 301.4 | Upgrade
|
| Book Value Per Share | 6.05 | 6.23 | 5.68 | 2.68 | 4.57 | Upgrade
|
| Tangible Book Value | 422.19 | 421.59 | 377.9 | 165.79 | 311.94 | Upgrade
|
| Tangible Book Value Per Share | 5.82 | 5.98 | 5.42 | 2.40 | 4.57 | Upgrade
|
| Machinery | 4.77 | 4.58 | 4.59 | 4.65 | 5.01 | Upgrade
|
| Construction In Progress | 0.16 | 0.01 | - | 0.17 | 0.1 | Upgrade
|
| Leasehold Improvements | 3.93 | 3.93 | 3.93 | 3.93 | 3.67 | Upgrade
|
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.